{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:31:07Z","timestamp":1791930667111,"version":"4.3.4"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014807","name":"Cancer Research Coordinating Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.576310","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T07:44:15Z","timestamp":1601365455000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity"],"prefix":"10.3389","volume":"11","author":[{"given":"Darienne R.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L.","family":"Abram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wildes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Belwafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia M. N.","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany J.","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tram","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Omaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rich","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A. M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford A.","family":"Lowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"key":"B2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.molmed.2018.03.006","article-title":"Macrophages: the road less traveled, changing anticancer therapy","volume":"24","author":"Guerriero","year":"2018","journal-title":"Trends Mol Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1158\/1078-0432.CCR-14-2520","article-title":"Molecular pathways: activating t cells after cancer cell phagocytosis from blockade of CD47 \u201cdon't eat me\u201d signals","volume":"21","author":"McCracken","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejca.2017.02.013","article-title":"Cancer immunotherapy targeting the CD47\/SIRPalpha axis","volume":"76","author":"Weiskopf","year":"2017","journal-title":"Eur J Cancer."},{"key":"B5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cell.2010.07.044","article-title":"Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma","volume":"142","author":"Chao","year":"2010","journal-title":"Cell."},{"key":"B6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/19420862.2015.1011450","article-title":"Macrophages are critical effectors of antibody therapies for cancer","volume":"7","author":"Weiskopf","year":"2015","journal-title":"MAbs."},{"key":"B7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000490106","article-title":"Targeting SHP-1, 2 and SHIP pathways: a novel strategy for cancer treatment?","volume":"95","author":"Dempke","year":"2018","journal-title":"Oncology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1042\/BST20150251","article-title":"SHP-1: the next checkpoint target for cancer immunotherapy?","volume":"44","author":"Watson","year":"2016","journal-title":"Biochem Soc Trans."},{"key":"B9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1189\/jlb.2MR0317-105R","article-title":"Shp1 function in myeloid cells","volume":"102","author":"Abram","year":"2017","journal-title":"J Leukoc Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1600-065X.2008.00760.x","article-title":"SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels","volume":"228","author":"Lorenz","year":"2009","journal-title":"Immunol Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/oxfordjournals.jhered.a108625","article-title":"Motheaten, an immunodeficient mutant of the mouse","volume":"66","author":"Green","year":"1975","journal-title":"I. Genetics and pathology. J Hered."},{"key":"B12","doi-asserted-by":"publisher","first-page":"15028","DOI":"10.1073\/pnas.0806619105","article-title":"Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger","volume":"105","author":"Croker","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.ajpath.2010.12.053","article-title":"Spontaneous insertion of a b2 element in the ptpn6 gene drives a systemic autoinflammatory disease in mice resembling neutrophilic dermatosis in humans","volume":"178","author":"Nesterovitch","year":"2011","journal-title":"Am J Pathol."},{"key":"B14","first-page":"179","article-title":"\u201cViable motheaten,\u201d a new allele at the motheaten locus. I. Pathology","volume":"116","author":"Shultz","year":"1984","journal-title":"Am J Pathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.4049\/jimmunol.0903562","article-title":"Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents","volume":"184","author":"Kundu","year":"2010","journal-title":"J Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1016\/j.bmcl.2013.03.028","article-title":"Learning from our mistakes: the 'unknown knowns' in fragment screening","volume":"23","author":"Davis","year":"2013","journal-title":"Bioorg Med Chem Lett."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/2211-5463.12493","article-title":"Off-target inhibition by active site-targeting SHP2 inhibitors","volume":"8","author":"Tsutsumi","year":"2018","journal-title":"FEBS Open Bio."},{"key":"B18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.immuni.2013.02.018","article-title":"Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice","volume":"38","author":"Abram","year":"2013","journal-title":"Immunity."},{"key":"B19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.celrep.2013.12.029","article-title":"Critical role for mast cell Stat5 activity in skin inflammation","volume":"6","author":"Ando","year":"2014","journal-title":"Cell Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.4049\/jimmunol.1001362","article-title":"SHP-1 in T cells limits the production of CD8 effector cells without impacting the formation of long-lived central memory cells","volume":"185","author":"Fowler","year":"2010","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1084\/jem.20122239","article-title":"Shp1 regulates T cell homeostasis by limiting IL-4 signals","volume":"210","author":"Johnson","year":"2013","journal-title":"J Exp Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.4049\/jimmunol.1103210","article-title":"Dendritic cell-specific ablation of the protein tyrosine phosphatase Shp1 promotes Th1 cell differentiation and induces autoimmunity","volume":"188","author":"Kaneko","year":"2012","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1038\/ncomms5273","article-title":"Shp1 signalling is required to establish the long-lived bone marrow plasma cell pool","volume":"5","author":"Li","year":"2014","journal-title":"Nat Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1182\/blood-2012-08-449272","article-title":"Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function","volume":"121","author":"Mazharian","year":"2013","journal-title":"Blood."},{"key":"B25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.immuni.2007.04.016","article-title":"B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity","volume":"27","author":"Pao","year":"2007","journal-title":"Immunity."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1038\/ncomms6108","article-title":"SHP-1-mediated inhibitory signals promote responsiveness and anti-tumour functions of natural killer cells","volume":"5","author":"Viant","year":"2014","journal-title":"Nat Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1084\/jem.183.2.371","article-title":"B and T cells are not required for the viable motheaten phenotype","volume":"183","author":"Yu","year":"1996","journal-title":"J Exp Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature22076","article-title":"SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin","volume":"544","author":"Chen","year":"2017","journal-title":"Nature."},{"key":"B29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.it.2017.12.005","article-title":"SIRPalpha-CD47 immune checkpoint blockade in anticancer therapy","volume":"39","author":"Veillette","year":"2018","journal-title":"Trends Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/jcb.23125","article-title":"Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation","volume":"112","author":"Wang","year":"2011","journal-title":"J Cell Biochem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"6516","DOI":"10.1074\/jbc.M210430200","article-title":"Crystal structure of human protein-tyrosine phosphatase SHP-1","volume":"278","author":"Yang","year":"2003","journal-title":"J Biol Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1164\/rccm.200711-1661OC","article-title":"Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha","volume":"178","author":"Janssen","year":"2008","journal-title":"Am J Respir Crit Care Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.1238856","article-title":"Engineered SIRPalpha variants as immunotherapeutic adjuvants to anticancer antibodies","volume":"341","author":"Weiskopf","year":"2013","journal-title":"Science."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1172\/JCI81603","article-title":"CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer","volume":"126","author":"Weiskopf","year":"2016","journal-title":"J Clin Invest."},{"key":"B35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jim.2014.05.009","article-title":"Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice","volume":"408","author":"Abram","year":"2014","journal-title":"J Immunol Methods."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-213X-1-4","article-title":"Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus","volume":"1","author":"Srinivas","year":"2001","journal-title":"BMC Dev Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05541","article-title":"Restoration of p53 function leads to tumour regression in vivo","volume":"445","author":"Ventura","year":"2007","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1084\/jem.194.12.1721","article-title":"Homeostatic competition among T cells revealed by conditional inactivation of the mouse Cd4 gene","volume":"194","author":"Wang","year":"2001","journal-title":"J Exp Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e15263","DOI":"10.1371\/journal.pone.0015263","article-title":"A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells","volume":"5","author":"Marim","year":"2010","journal-title":"PLoS ONE."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41596-018-0069-7","article-title":"CRISPR-Cas9 genome engineering of primary CD4(+) T cells for the interrogation of HIV-host factor interactions","volume":"14","author":"Hultquist","year":"2019","journal-title":"Nat Protoc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nm.3931","article-title":"CD47 blockade triggers T cell-mediated destruction of immunogenic tumors","volume":"21","author":"Liu","year":"2015","journal-title":"Nat Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejmg.2005.03.001","article-title":"Germ-line and somatic PTPN11 mutations in human disease","volume":"48","author":"Tartaglia","year":"2005","journal-title":"Eur J Med Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/358646a0","article-title":"Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides","volume":"358","author":"Waksman","year":"1992","journal-title":"Nature."},{"key":"B44","doi-asserted-by":"publisher","first-page":"11103","DOI":"10.1073\/pnas.1305569110","article-title":"Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response","volume":"110","author":"Tseng","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMoa1807315","article-title":"CD47 blockade by Hu5F9-G4 and rituximab in non-hodgkin's lymphoma","volume":"379","author":"Advani","year":"2018","journal-title":"N Engl J Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat Rev Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"aax6337","DOI":"10.1126\/scitranslmed.aax6337","article-title":"Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses","volume":"12","author":"Jaynes","year":"2020","journal-title":"Sci Transl Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/labinvest.2009.32","article-title":"Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype","volume":"89","author":"Christophi","year":"2009","journal-title":"Lab Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/978-1-59745-471-1_18","article-title":"Inducible Cre mice","volume":"530","author":"Feil","year":"2009","journal-title":"Methods Mol Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.gastro.2011.09.050","article-title":"Tamoxifen induces rapid, reversible atrophy, and metaplasia in mouse stomach","volume":"142","author":"Huh","year":"2012","journal-title":"Gastroenterology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1158\/2326-6066.CIR-16-0114","article-title":"Rational selection of syngeneic preclinical tumor models for immunotherapeutic drug discovery","volume":"5","author":"Mosely","year":"2017","journal-title":"Cancer Immunol Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"682","DOI":"10.2174\/1568009617666170427102729","article-title":"Impact of IL-12 in Cancer","volume":"17","author":"Lu","year":"2017","journal-title":"Curr Cancer Drug Targets."},{"key":"B53","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/ni.1604","article-title":"Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1","volume":"9","author":"An","year":"2008","journal-title":"Nat Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.4049\/jimmunol.1001675","article-title":"The phosphatase SRC homology region 2 domain-containing phosphatase-1 is an intrinsic central regulator of dendritic cell function","volume":"186","author":"Ramachandran","year":"2011","journal-title":"J Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.4049\/jimmunol.1200552","article-title":"Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo","volume":"189","author":"Stromnes","year":"2012","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4049\/jimmunol.1602171","article-title":"T cells deficient in the tyrosine phosphatase shp-1 resist suppression by regulatory t cells","volume":"199","author":"Mercadante","year":"2017","journal-title":"J Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.cell.2018.10.024","article-title":"Genome-wide CRISPR Screens in primary human t cells reveal key regulators of immune function","volume":"175","author":"Shifrut","year":"2018","journal-title":"Cell."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.576310\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T07:44:22Z","timestamp":1601365462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.576310\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2020.576310"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.576310","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"article-number":"576310"}}